1992
DOI: 10.1016/0007-1935(92)90026-w
|View full text |Cite
|
Sign up to set email alerts
|

Equine chondrocyte activation by a variety of stimuli

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
11
0

Year Published

1992
1992
2008
2008

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(13 citation statements)
references
References 25 publications
1
11
0
Order By: Relevance
“…Equine IL‐1 has been identified and characterized, 8,9,49 and exhibits a similar molecular‐weight, isoelectric point, and >80% homology with human IL‐1 9,22 . Cross‐reactivity of the anti‐human IL‐1 antibody to equine‐origin IL‐1 would be expected 16,37–40 . Parallelism of ELISA‐derived concentrations of equine proteins with human proteins has been reported for thrombin–antithrombin III complexes 50,51 .…”
Section: Discussionmentioning
confidence: 93%
“…Equine IL‐1 has been identified and characterized, 8,9,49 and exhibits a similar molecular‐weight, isoelectric point, and >80% homology with human IL‐1 9,22 . Cross‐reactivity of the anti‐human IL‐1 antibody to equine‐origin IL‐1 would be expected 16,37–40 . Parallelism of ELISA‐derived concentrations of equine proteins with human proteins has been reported for thrombin–antithrombin III complexes 50,51 .…”
Section: Discussionmentioning
confidence: 93%
“…NO and PGE2 were shown to be produced by synoviocytes and chondrocytes of different species as an immediate reaction to a variety of stimuli (Stadler et al, 1991 ;Evans, 1992;May eI al., 1992', Mort et al, 1993Palmer et al, 1993;Frean et al, 1997). Most of these studies were carried out with normal synovial membrane and afticular cartilage specimens that were subjected to stimulation with cytokines, such as interleukin-1 (lL-1) (Bandara et al, 1989;May et al, 1992;Stefanovic-Racrc et al, 1993b;Frean eI al., 1997), tumor necrosis factor B [NF-B) $tadler et al, 1991) and lipopolysaccharides from bacterial wall fragments (LPS) (Maier et al, 1992', May et al, 1992', BirkedalHansen, 1993MacDonald et al, 1994;Frean et al, 1997). Measurements of NO production by monolayer cell cultures of equine synovial membrane and articular cartilage after stimulation with lL-1 B and LPS showed that both cell types were capable of releasing this mediator, but that synoviocytes produced less than chondrocytes (Evans et al, 1996;Frean et al, 1997).…”
Section: Pferdeheilkunde 15mentioning
confidence: 99%
“…1 In the Thoroughbred racehorse industry worldwide, musculoskeletal injury accounts for the highest proportion of days lost from training [2][3][4][5] and is the most common cause of athletic morbidity. [9][10][11][12][13] Intra-articular analgesics (mepivacaine, lidocaine, and bupivacaine 14 ) and intraarticular therapeutic agents (corticosteroids, polysulfated Anti-inflammatory and analgesic effects of intra-articular injection of triamcinolone acetonide, mepivacaine hydrochloride, or both on lipopolysaccharide-induced lameness in horses glycosaminoglycans, and hyaluronic acid derivatives) remain important aids in the diagnosis of acute synovitis and treatment of affected horses and help in the prevention of additional degenerative articular changes. [9][10][11][12][13] Intra-articular analgesics (mepivacaine, lidocaine, and bupivacaine 14 ) and intraarticular therapeutic agents (corticosteroids, polysulfated Anti-inflammatory and analgesic effects of intra-articular injection of triamcinolone acetonide, mepivacaine hydrochloride, or both on lipopolysaccharide-induced lameness in horses glycosaminoglycans, and hyaluronic acid derivatives) remain important aids in the diagnosis of acute synovitis and treatment of affected horses and help in the prevention of additional degenerative articular changes.…”
mentioning
confidence: 99%